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A 68-year-old man presented with a 3-week history of pyrexia of unknown origin. He also suffered 
from malaise, night sweats, rigors and weight loss but had no localizing symptoms. Pyrexia of unknown 
origin has a wide array of differential diagnoses and it can be challenging to find the correct diagnosis 
promptly. Examination of the patient indicated pallor and features of long-standing aortic regurgitation, 
but was otherwise unremarkable. Due to his history of valvular disease and a recent dental extraction, 
his investigations were tailored towards infective endocarditis. Blood cultures and echocardiography 
confirmed this diagnosis by Dukes’ criteria. He promptly received antibiotics, made a full recovery and 
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Pyrexia of unknown origin is defined as a 
fever of 38.3°C or more lasting at least 3 
weeks and for which no cause can be 
identified after 3 days of investigations in 
hospital or after 3 or more outpatient visits.1 
There are few other clinical presentations 
that produce such a wide array of differential 
diagnoses, including infections, malignancy 
and connective tissue disorders.2 Due to the 
high mortality rate of many of these 
conditions, especially if diagnosis is delayed, 
a high degree of suspicion is imperative. 
Thorough clinical assessment is vital to 
provide diagnostic clues and tailor 
investigations.2 
 
Here, we report a case of pyrexia of 
unknown origin, which was found to be due 
to infective endocarditis (IE) in a gentleman 
with Marfan syndrome. IE is a rare 
endocardial infection with an annual 
incidence of 3–10 cases per 100,000 per 
annum.3 It can be bacterial, viral or fungal, 
predominately affecting those over age 60 
and twice as many men as women.4 Over 
50% have underlying heart problems (e.g. 
valvular disease) and intravenous drug use is 
an important risk factor.3 Unfortunately, 
diagnosis is commonly delayed as symptoms 
are often non-specific. Diagnosis is by 
Dukes’ criteria.4 Treatment is frequently with 
antibiotics, but surgery is indicated in 
uncontrolled infection, heart failure or 
embolic event.3,6 Prompt diagnosis is vital as 
mortality rates of between 14–46% have 
been reported and complications include 
congestive heart failure and stroke.7 
 
Marfan syndrome, an additional uncommon 
condition affecting this patient, is an 
autosomal dominant disorder affecting 
fibrillin-1 (an extracellular matrix protein), 
which causes weakening of connective 
tissue. Common features are lens 
dislocation, skeletal features (e.g. 
arachnodactyly, scoliosis) and dural ectasia. 
Cardiac features include valve incompetence, 
such as in this case, and aortic dissection, 
which often requires monitoring and 
medication.8 
 
Here, we describe the difficulty in 
diagnosing IE due to its non-specific 
presentation. We also aim to highlight how 
considering a patient’s characteristics can aid 
in the diagnosis of a non-specific complaint 
such as pyrexia of unknown origin. Finally, 
we discuss the guidelines for the use of 





A 68-year-old gentleman with Marfan 
syndrome presented with a 3-week history 
of malaise and fever, and a 2-week history of 
rigors and night sweats. His appetite was 
poor, he had lost 2 kg of weight and felt 
slightly nauseated, but denied vomiting. He 
had no rashes or skin lesions and denied any 
other symptoms on systemic enquiry. His 
past medical history included aortic 
regurgitation (moderate and asymptomatic), 
essential hypertension, hyper- 
cholesterolaemia and benign prostatic 
hyperplasia (BPH), but he had no history of 
malignancy or long-standing infections. He 
is a retired, married, non-smoker and is fully 
independent. He denied recent foreign travel 
or intravenous drug use but had a dental 
extraction the previous month. 
 
On general inspection, conjunctival pallor 
was present but there was no jaundice, 
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38.5°C but his other observations were all 
normal. On cardiovascular examination, he 
had no splinter haemorrhages, finger 
clubbing, Osler’s nodes or Janeway lesions. 
He had a collapsing radial pulse and a visible 
carotid pulsation (Corrigan’s sign). His 
dentition was good and his JVP was not 
elevated. He had no palpable heaves or 
thrills but his apex beat had a heaving  
 
character in the sixth intercostal space, 
displaced 2 cm laterally of the midclavicular 
line. Heart sounds I + II were present with 
an early diastolic murmur (intensity grade 3), 
suggestive of aortic regurgitation. Peripheral 
pulses were normal. Examination of other 




Differential Diagnosis Factors Supporting Factors Against 
Infective Endocarditis Aortic regurgitation. 
Recent dental extraction.  
No features of IE on examination (e.g. 
Janeway lesions, Osler’s nodes)  
Other Infections  
e.g. abscesses, oral cavity 
infections or bone infections  
Infective symptoms and 
prolonged pyrexia. 
No obvious source of infection or 
localized symptoms to suggest site (e.g. 
hepatobiliary, diverticular, urinary) 
Haematological 
malignancy  
e.g. lymphoma, leukaemia, 
myeloma  
Pyrexia, cachexia, night 
sweats, weight loss. Many 
haematological 
malignancies commonly 
occur in >60yrs. Anaemic 
on examination.  
No lymphadenopathy, hepatomegaly 
or splenomegaly. No clinical evidence 
of thrombocytopenia (e.g. bruising). 
No compression features typical of 
lymphoma.   
Other Malignancies 
e.g. lung, colorectal, renal 
Rapid weight loss, pallor 
on examination.  
No localizing clinical signs or 
symptoms. No lymphadenopathy on 
examination.   
Tuberculosis  Pyrexia, rigors, night 
sweats, weight loss.  
No respiratory symptoms. No history 




e.g. polymyalgia rheumatica 
(PMR), systemic lupus 
erythematosus (SLE), 
vasculitis  
Malaise, pallor on 
examination. 
No proximal muscle features typical of 
PMR, vasculitic rash or multisystemic 
features of SLE.  
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The patient was anaemic (Hb 8.6 g/L) with 
a neutrophilia and raised c-reactive protein. 
Blood cultures were positive for viridians 
streptococci. Urinalysis and throat swab 
showed no organisms. An ECG, chest X-ray 
and abdominal CT scan were unremarkable. 
A transoesophageal echocardiogram 
indicated vegetation attached to the aortic 
valve and ventricular septum. The diagnosis 
of IE was made by the modified Duke’s 
Criteria4 on the fourth day of admission. No 
other source of infection was found.  
 
Management, Outcome & Follow 
up  
 
The patient was promptly prescribed 
intravenous benzylpenicillin and gentamicin 
as per BSAC guidelines.4 He was also 
prescribed paracetamol and 
thromboembolism prophylaxis. His clinical 
response and observations were monitored 
closely. A repeat echocardiogram was 
arranged the following week to assess valve 
function, vegetation size and if surgical 
repair was required. The patient responded 
well to antibiotics and did not require 
surgery. He continued on benzylpenicillin 
for 4 weeks and gentamicin for 2 weeks and 
was discharged home.    
 
Discussion 
Pyrexia of unknown origin has a wide range 
of differential diagnoses and requires 
prompt and appropriate investigations. IE is 
an important differential diagnosis and, due 
to its often non-specific presentation, it 
requires a high degree of suspicion. It has 
been reported that around 25% of those 
with IE have clinical signs for over one 
month before admission to hospital.9 Delay 
can lead to devastating and even multiple 
complications, for example cases of multiple 
embolic events and renal failure or splenic 
rupture and fatal intra-abdominal 
haemorrhage have been reported.10,11 
 
Prompt blood cultures and transoesophageal 
echocardiography are necessary to confirm 
the diagnosis of IE. Clinical examination is 
essential for excluding other causes and 
aiding diagnosis. Signs on examination 
include cardiac murmurs (which are present 
in around 50%) and vasculitic rashes.3 
However, classical signs including Janeway 
lesions or subconjuctival haemorrhages are 
only present in a minority and, therefore, 
their absence does not exclude the diagnosis, 
as illustrated by this case.9 
 
In this case, acknowledging the patient’s risk 
factors aided the prognosis, which included 
his valvular heart disease related to Marfan 
syndrome and a recent dental extraction. 
This indicates the importance of taking a 
thorough history and having an awareness of 
risk factors. Between 1955 and 2008, 
prophylactic antibiotics were prescribed as a 
preventative measure to those undergoing 
interventional procedures who were deemed 
to have a high risk of IE (e.g. those with 
valvular diseases). However, new guidelines 
published by NICE in 2008 stated it was no 
longer recommended to offer antibiotic 
prophylaxis as the potential benefits are 
minimal.12 It is possible that prophylactic 
antibiotics in this case could have prevented 
the development of IE. A similar case in 
2011 was reported, where a patient with a 
congenital heart defect developed IE after a 
dental procedure, and the authors speculated 
whether the new guidelines were wise.13 This 
was reiterated by another case describing a 
previously independent 69-year-old man 
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poor dentition, who developed IE 10 days 
after a dental procedure.14 He unfortunately 
developed a cerebrovascular complication 
and died. The authors questioned whether 
strict adherence to the new guidelines is 
appropriate and suggested the decision 
should be made by case by case decisions.14 
Interestingly, the American Heart 
Association and the European Society for 
Cardiology both recommend prophylaxis for 
high risk individuals.15,16 From these cases it 
is clear that clinicians should be aware that a 
history of a recent interventional procedure, 
especially in susceptible individuals, is an 































Key Learning Points 
 
 Pyrexia of unknown origin has a wide 
range of differential diagnoses including 
infections, malignancies and connective 
tissue disorders.  
 
 Infective endocarditis is a rare infection 
which can present with non-specific 
complaints, such as pyrexia and malaise. 
 
 It generally affects elderly patients and 
other risk factors include intravenous 
drug use, valvular disease, prosthetic 
valves and cyanotic congenital heart 
disease.  
 
 Having a high degree of suspicion of 
endocarditis is necessary for prompt 
diagnosis and management as mortality is 
high.   
 
 NICE guidelines state that prophylactic 
antibiotics are no longer recommended as 
a preventative measure in those who are 
deemed to have a high risk of infective 
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